Total Visits

Views
Phase I trial of 6-hour infusion of glufosfamide, a new alkylating agent with potentially enhanced selectivity for tumors that overexpress transmembrane glucose transporters: A study of the European Organization for Research and Treatment of Cancer Early Clinical Studies Group128

Total Visits Per Month

Μάρτιος 2024Απρίλιος 2024Μάϊος 2024Ιούνιος 2024Ιούλιος 2024Αύγουστος 2024Σεπτέμβριος 2024
Phase I trial of 6-hour infusion of glufosfamide, a new alkylating agent with potentially enhanced selectivity for tumors that overexpress transmembrane glucose transporters: A study of the European Organization for Research and Treatment of Cancer Early Clinical Studies Group3014051

Top country views

Views
Πολωνία62
Ηνωμένες Πολιτείες44
Κίνα7
Γαλλία4
Σουηδία4
Γερμανία2
Ιρλανδία2
Αυστραλία1
Ινδία1

Top cities views

Views
Warsaw62
Boardman7
San Ramon7
San Diego5
Ann Arbor4
Beijing4
San Mateo4
Des Moines3
Mountain View3
Dublin2